Drug information for RIVASTIGMINE TARTRATE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL EQ 1.5MG BASE Prescription AB  RIVASTIGMINE TARTRATE rivastigmine WATSON LABS 77129
CAPSULE; ORAL EQ 3MG BASE Prescription AB  RIVASTIGMINE TARTRATE rivastigmine WATSON LABS   "
CAPSULE; ORAL EQ 4.5MG BASE Prescription AB  RIVASTIGMINE TARTRATE rivastigmine WATSON LABS   "
CAPSULE; ORAL EQ 6MG BASE Prescription AB  RIVASTIGMINE TARTRATE rivastigmine WATSON LABS   "
CAPSULE; ORAL EQ 1.5MG BASE Prescription AB  RIVASTIGMINE TARTRATE rivastigmine DR REDDYS LABS INC 77130
2007-11-08 Letter
CAPSULE; ORAL EQ 3MG BASE Prescription AB  RIVASTIGMINE TARTRATE rivastigmine DR REDDYS LABS INC   "
CAPSULE; ORAL EQ 4.5MG BASE Prescription AB  RIVASTIGMINE TARTRATE rivastigmine DR REDDYS LABS INC   "
CAPSULE; ORAL EQ 6MG BASE Prescription AB  RIVASTIGMINE TARTRATE rivastigmine DR REDDYS LABS INC   "
CAPSULE; ORAL EQ 1.5MG BASE Prescription AB  RIVASTIGMINE TARTRATE rivastigmine SUN PHARM INDS 77131
2007-10-25 Letter
CAPSULE; ORAL EQ 3MG BASE Prescription AB  RIVASTIGMINE TARTRATE rivastigmine SUN PHARM INDS   "
CAPSULE; ORAL EQ 4.5MG BASE Prescription AB  RIVASTIGMINE TARTRATE rivastigmine SUN PHARM INDS   "
CAPSULE; ORAL EQ 6MG BASE Prescription AB  RIVASTIGMINE TARTRATE rivastigmine SUN PHARM INDS   "
CAPSULE; ORAL EQ 1.5MG BASE Tentative Approval  (Reference Drug) RIVASTIGMINE TARTRATE rivastigmine ORCHID HLTHCARE 90879
CAPSULE; ORAL EQ 3MG BASE Tentative Approval  (Reference Drug) RIVASTIGMINE TARTRATE rivastigmine ORCHID HLTHCARE   "
CAPSULE; ORAL EQ 4.5MG BASE Tentative Approval  (Reference Drug) RIVASTIGMINE TARTRATE rivastigmine ORCHID HLTHCARE   "
CAPSULE; ORAL EQ 6MG BASE Tentative Approval  (Reference Drug) RIVASTIGMINE TARTRATE rivastigmine ORCHID HLTHCARE   "
CAPSULE; ORAL 1.5MG Tentative Approval   RIVASTIGMINE TARTRATE rivastigmine ALEMBIC PHARMS LTD 91689
CAPSULE; ORAL 3MG Tentative Approval   RIVASTIGMINE TARTRATE rivastigmine ALEMBIC PHARMS LTD   "
CAPSULE; ORAL 4.5MG Tentative Approval   RIVASTIGMINE TARTRATE rivastigmine ALEMBIC PHARMS LTD   "
CAPSULE; ORAL 6MG Tentative Approval   RIVASTIGMINE TARTRATE rivastigmine ALEMBIC PHARMS LTD   "

Drug Adverse Effects information for RIVASTIGMINE TARTRATE

Role code Indications Reaction # Reports
PS CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE HEART RATE ABNORMAL 1
PS CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE SYNCOPE 1
PS DEMENTIA HEART RATE ABNORMAL 1
PS DEMENTIA SYNCOPE 1
PS DEMENTIA ALZHEIMER'S TYPE AKINESIA 1
PS DEMENTIA ALZHEIMER'S TYPE CONVULSION 1
PS DEMENTIA ALZHEIMER'S TYPE PANIC ATTACK 1
PS HYPERTENSION HEART RATE ABNORMAL 1
PS HYPERTENSION SYNCOPE 1
PS PARKINSON'S DISEASE HEART RATE ABNORMAL 1
PS PARKINSON'S DISEASE SYNCOPE 1
SS CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE HEART RATE ABNORMAL 1
SS CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE SYNCOPE 1
SS DEMENTIA HEART RATE ABNORMAL 1
SS DEMENTIA SYNCOPE 1
SS HYPERTENSION HEART RATE ABNORMAL 1
SS HYPERTENSION SYNCOPE 1
SS PARKINSON'S DISEASE HEART RATE ABNORMAL 1
SS PARKINSON'S DISEASE SYNCOPE 1
C ANALGESIC THERAPY BLOOD URINE PRESENT 1
C ARRHYTHMIA ANXIETY 1
C ARRHYTHMIA CEREBROVASCULAR ACCIDENT 1
C ARRHYTHMIA DEMENTIA ALZHEIMER'S TYPE 1
C ARRHYTHMIA INCORRECT ROUTE OF DRUG ADMINISTRATION 1
C ARRHYTHMIA NERVOUSNESS 1
C ARRHYTHMIA WEIGHT INCREASED 1
C BLOOD CHOLESTEROL ANXIETY 1
C BLOOD CHOLESTEROL CEREBROVASCULAR ACCIDENT 1
C BLOOD CHOLESTEROL DEMENTIA ALZHEIMER'S TYPE 1
C BLOOD CHOLESTEROL INCORRECT ROUTE OF DRUG ADMINISTRATION 1
C BLOOD CHOLESTEROL NERVOUSNESS 1
C BLOOD CHOLESTEROL WEIGHT INCREASED 1
C GASTROINTESTINAL STROMAL TUMOUR DRUG INEFFECTIVE 2
C GASTROINTESTINAL STROMAL TUMOUR GASTROINTESTINAL STROMAL TUMOUR 2
C GASTROINTESTINAL STROMAL TUMOUR NEOPLASM MALIGNANT 2
C GASTROINTESTINAL STROMAL TUMOUR PELVIC MASS 2
C GASTROINTESTINAL STROMAL TUMOUR RENAL CYST 2
C GASTROINTESTINAL STROMAL TUMOUR WEIGHT DECREASED 2
C HYPERTENSION ACCIDENTAL OVERDOSE 2
C HYPERTENSION ANXIETY 3
C HYPERTENSION CEREBROVASCULAR ACCIDENT 3
C HYPERTENSION DEMENTIA ALZHEIMER'S TYPE 3
C HYPERTENSION HYPOTENSION 2
C HYPERTENSION INCORRECT ROUTE OF DRUG ADMINISTRATION 3
C HYPERTENSION NERVOUSNESS 3
C HYPERTENSION WEIGHT INCREASED 3
C MUSCULOSKELETAL PAIN ANXIETY 1
C MUSCULOSKELETAL PAIN CEREBROVASCULAR ACCIDENT 1
C MUSCULOSKELETAL PAIN DEMENTIA ALZHEIMER'S TYPE 1
C MUSCULOSKELETAL PAIN INCORRECT ROUTE OF DRUG ADMINISTRATION 1
C MUSCULOSKELETAL PAIN NERVOUSNESS 1
C MUSCULOSKELETAL PAIN WEIGHT INCREASED 1
C PARKINSON'S DISEASE DRUG INEFFECTIVE 4
C PARKINSON'S DISEASE GASTROINTESTINAL STROMAL TUMOUR 4
C PARKINSON'S DISEASE NEOPLASM MALIGNANT 4
C PARKINSON'S DISEASE PELVIC MASS 4
C PARKINSON'S DISEASE RENAL CYST 4
C PARKINSON'S DISEASE WEIGHT DECREASED 4
C PRODUCT USED FOR UNKNOWN INDICATION ANXIETY 8
C PRODUCT USED FOR UNKNOWN INDICATION CEREBROVASCULAR ACCIDENT 8
C PRODUCT USED FOR UNKNOWN INDICATION DEMENTIA ALZHEIMER'S TYPE 8
C PRODUCT USED FOR UNKNOWN INDICATION INCORRECT ROUTE OF DRUG ADMINISTRATION 8
C PRODUCT USED FOR UNKNOWN INDICATION NERVOUSNESS 8
C PRODUCT USED FOR UNKNOWN INDICATION WEIGHT INCREASED 8
C RHEUMATOID ARTHRITIS ANXIETY 1
C RHEUMATOID ARTHRITIS CEREBROVASCULAR ACCIDENT 1
C RHEUMATOID ARTHRITIS DEMENTIA ALZHEIMER'S TYPE 1
C RHEUMATOID ARTHRITIS INCORRECT ROUTE OF DRUG ADMINISTRATION 1
C RHEUMATOID ARTHRITIS NERVOUSNESS 1
C RHEUMATOID ARTHRITIS WEIGHT INCREASED 1
Ads by Google